Tuğba Koçmar

Tuğba Koçmar

Auto-generated profile, based on publicly available information

Tuğba Koçmar

Marmara University, Institute of Health Sciences

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
TKTuğba Koçmar
Tuğba Koçmar
EÇElif ÇAĞLAYAN
Elif ÇAĞLAYAN
ERErkan Rayaman
Erkan Rayaman
KNKyosuke Nagata
Kyosuke Nagata
KTKadir Turan
Kadir Turan

31 December 2025 in Hacettepe Journal of Biology and Chemistry
Verified
Journal Article
Closed access
KTKadir Turan
Kadir Turan
EÇElif ÇAĞLAYAN
Elif ÇAĞLAYAN
PUPınar Ulupınar
Pınar Ulupınar
TKTuğba Koçmar
Tuğba Koçmar
Favipiravir is a nucleoside analog that is a selective and potent inhibitor of influenza virus RNA-dependent RNA polymerase (RdRp). This drug is considered to be a potential inhibitor of RNA viruses other than influenza due to its effect on the RdRp. In this study, we evaluated the effects of favipiravir on expression of interferon-related genes in alveolar epithelial cells (A549 and BEAS-2B) which produce various types of chemokines. The cytotoxicity and anti-RdRp activity of favipiravir were examined by MTT and virus minireplicon assays, respectively. Favipiravir strongly inhibited human (A/WSN/33-H1N1) and avian type of influenza (A/duck/Pennsylvania-H5N2) virus RdRp at nontoxic doses. The gene transcripts in the cells treated with different doses of favipiravir were analyzed by qPCR and immunoblotting. While CCL2, CAV1 and PRKCZ genes were among the most downregulated genes; IFNB1, IFNE and IL10 genes were the most upregulated in favipiravir-treated cells. The CCL2 and INFB1 transcripts were the most significantly differentiated by favipiravir treatment. The BEAS-2B cells were less sensitive to favipiravir-treatment compared to A549. From this result, it was concluded that favipiravir, while primarily inhibiting the viral RdRp, may also affect cellular interferon defense mechanisms and interfere with virus replication.